SEC Form 4 · accession 0001209191-19-000614
AtriCure, Inc. · ATRC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael H Carrel
Officer — President, CEO, & Director · Director
Period of report
Dec 31, 2018
Accepted (ET)
Jan 3, 2019 · 7:50 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001323885
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 31, 2018 | A | 296 | $24.00 | A | 713,092 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2018.
- F2In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 2, 2018, which was the first trading day of the applicable offering period. The closing price on July 2, 2018 was $28.24.